<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>titanium implant &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/titanium-implant/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Thu, 01 Oct 2026 09:15:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>titanium implant &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>3D-Printed Bone-Anchored Prosthesis Shows Promise in Preclinical Tests</title>
		<link>https://scienmag.com/3d-printed-bone-anchored-prosthesis-shows-promise-in-preclinical-tests/</link>
		
		<dc:creator><![CDATA[Denise Maddox]]></dc:creator>
		<pubDate>Thu, 01 Oct 2026 09:15:34 +0000</pubDate>
				<category><![CDATA[Medicine]]></category>
		<category><![CDATA[3D printing]]></category>
		<category><![CDATA[3D printing in prosthetic engineering]]></category>
		<category><![CDATA[3D-printed bone-anchored prosthesis]]></category>
		<category><![CDATA[amputation]]></category>
		<category><![CDATA[biocompatibility]]></category>
		<category><![CDATA[biomechanical analysis of bone-anchored prostheses]]></category>
		<category><![CDATA[biomechanics]]></category>
		<category><![CDATA[bone anchoring]]></category>
		<category><![CDATA[clinical challenges in limb prosthetics]]></category>
		<category><![CDATA[cloverleaf sleeve]]></category>
		<category><![CDATA[enhancing prosthetic limb stability and comfort]]></category>
		<category><![CDATA[finite element analysis]]></category>
		<category><![CDATA[infection prevention in prosthetic implants]]></category>
		<category><![CDATA[innovative designs for osseointegration systems]]></category>
		<category><![CDATA[large-animal model for prosthesis development]]></category>
		<category><![CDATA[osseointegration]]></category>
		<category><![CDATA[osseointegration limb prosthesis]]></category>
		<category><![CDATA[overcoming prosthesis implant failure modes]]></category>
		<category><![CDATA[preclinical study]]></category>
		<category><![CDATA[preclinical testing of osseointegration implants]]></category>
		<category><![CDATA[prosthesis]]></category>
		<category><![CDATA[regenerative engineering for limb]]></category>
		<category><![CDATA[residual limb]]></category>
		<category><![CDATA[titanium implant]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=221638</guid>

					<description><![CDATA[A 3D-printed osseointegration prosthesis featuring a cloverleaf sleeve showed superior stress distribution, stable fixation and favorable bone integration in preclinical computational and sheep models.]]></description>
										<content:encoded><![CDATA[<p>For millions of people living with limb amputation, the socket that connects flesh to prosthetic limb remains the weakest link in an otherwise remarkable chain of engineering. Straps, liners and vacuum systems transmit forces through soft tissue that was never designed to bear load, producing pain, skin breakdown and a prosthesis many patients simply abandon. Osseointegration — anchoring the artificial limb directly into the bone of the residual limb — promises a fundamentally different interface, one that restores proprioceptive feedback, improves range of motion and allows all-day wear. Yet the technique has been held back by real clinical concerns: infection at the skin-implant junction, implant fracture, bone loss around the stem and loosening under the enormous repetitive loads of walking. A new preclinical study from Peking University People&#8217;s Hospital, published in the Annals of Biomedical Engineering, describes a 3D-printed osseointegration prosthesis system engineered specifically to attack those failure modes, and reports encouraging early results from computational modeling and a large-animal model.</p>
<p>The research team, led by corresponding author Jun Wang of the Department of Musculoskeletal Tumor, designed their osseointegration prosthesis, or OIP, as a family of configurations rather than a single device. The system was categorized into four types distinguished by fixation strategy and rotational control. Type I implants rely solely on intramedullary press-fit fixation, in which a stem is wedged tightly into the reamed canal of the femur. Type II adds an extramedullary sleeve that sits outside the bone, reinforcing the construct from the cortical surface inward. Within each of those categories, a suffix distinguishes devices with no auxiliary anti-rotation screws (Type a) from those that add such screws (Type b) to resist torsional loads. This modular taxonomy allowed the investigators to isolate, in silico, exactly how much each design feature contributes to mechanical stability — a level of design transparency that is rare in the implant literature.</p>
<p>The defining hardware innovation is the extramedullary cloverleaf sleeve, whose inner wall and the surface of the intramedullary stem are coated with 3D-printed metal porous structures. Porous titanium lattices of this kind serve two purposes simultaneously. Mechanically, they create a frictional, interlocking surface that grips bone during the critical early period before biological fixation matures. Biologically, their interconnected pores invite bone to grow into the implant, converting a press-fit mechanical wedge into a living, load-sharing composite of metal and bone. Additive manufacturing is what makes this feasible: conventional machining cannot produce the intricate, graded porosity that 3D printing lays down layer by layer, and the same digital workflow means a patient-specific implant can in principle be printed from computed tomography data of the individual&#8217;s residual femur.</p>
<p>Before any animal was operated on, the team subjected the four design variants to rigorous finite element analysis. Finite element analysis, or FEA, is a computational technique that divides a complex structure into thousands of small elements and solves the equations of elasticity for each, producing maps of stress and displacement that would be impossible to measure directly inside a living limb. The researchers built their models from adult femoral CT data, ensuring that the geometry and material distribution of the bone reflected real anatomy rather than an idealized cylinder. They then simulated two clinically meaningful loading scenarios: vertical compressive loads of 600 and 900 newtons, approximating the forces transmitted through the femur during stance phase and more demanding activities, and torsional moments of 15,000 and 20,000 newton-millimeters, representing the twisting loads generated when the foot pivots or the patient stumbles.</p>
<p>The computational results delivered a clear verdict on the cloverleaf sleeve. Prostheses equipped with the extramedullary sleeve exhibited lower peak stresses under high vertical loading and a more dispersed stress distribution across the bone-implant interface compared with intramedullary fixation alone. They also demonstrated superior resistance to displacement, meaning the construct was less likely to subside or rotate under load. This matters because stress concentration is the silent killer of orthopedic implants: where stress piles up at a single point on the bone-implant interface, bone resorbs, micromotion increases, and the fixation spirals toward aseptic loosening. By spreading load over a broader area and shielding the cortical bone with the sleeve, the Type II design mimics the way a healthy femur distributes the forces of gait — a principle biomechanists call favorable load transfer. The FEA contour plots gave the team the quantitative evidence needed to select the optimal configuration for the animal phase.</p>
<p>That animal phase was the study&#8217;s most ambitious component. The researchers constructed a mid-femoral amputation model in Small-tailed Han sheep, using three animals, and implanted the Type IIa prosthesis — the combined intramedullary press-fit and extramedullary sleeve design without auxiliary anti-rotation screws. The surgical protocol mirrored what would eventually be proposed for human patients: the intramedullary cavity was reamed to accept the stem, and the cortical bone was decorticated, a technique that removes the dense outer layer to stimulate bleeding and activate the bone-healing response at the implant surface. Sheep are a demanding test bed for orthopedic implants because their bone remodeling rates and loading patterns approximate the human situation better than smaller rodents, and because a transcutaneous implant in a quadruped endures constant, uncontrolled loading.</p>
<p>The outcomes reported from the sheep model were strikingly positive. The implants achieved stable fixation, with no obvious infection developing around the transcutaneous components — historically the single most feared complication of osseointegration, since a permanent opening through the skin provides a potential highway for bacteria to reach the bone. Blood parameters monitored in the study, including white blood cell count, platelet count and hemoglobin, served as systemic indicators of inflammatory response and overall biocompatibility. Most importantly, histological and mechanical evaluation demonstrated favorable osseointegration between the prosthesis and the femur, confirming that the 3D-printed porous surfaces had done their biological job: bone had grown into and bonded with the implant&#8217;s lattice architecture, transforming a mechanical press-fit into durable biological fixation.</p>
<p>The significance of this work lies in its methodological completeness. Rather than presenting either a purely computational study or an isolated animal experiment, the team built a preclinical pipeline in which finite element analysis guided design selection, and the selected design was then validated in a large-animal model assessing functional reconstruction, biocompatibility and osseointegration together. The authors state explicitly that the newly designed OIP possesses good biocompatibility and osseointegration capacity, and that the extramedullary cloverleaf sleeve enhances the mechanical properties of the construct — laying what they describe as a theoretical foundation for future clinical application. The work was funded by the National Natural Science Foundation of China, the Beijing Natural Science Foundation Innovation Joint Fund and the Research and Development Fund of Peking University People&#8217;s Hospital, and all animal procedures were approved by the institutional animal care and ethics committees at Peking University People&#8217;s Hospital.</p>
<p>Caution is still warranted before celebrating a clinical breakthrough. Three sheep constitute a small sample, and the study is explicitly preclinical: no human data exist yet for this specific device, and the long-term behavior of the implant — years of cyclic loading, the durability of the skin seal, the response to accidental overload — remains untested. Existing osseointegration systems such as the OPRA implant and the OPL have already demonstrated in human trials that bone-anchored prostheses can dramatically improve mobility and quality of life, but systematic reviews have catalogued complication rates that include soft-tissue infections, implant fractures and revisions. What the Peking University study contributes is a rational, computationally verified design intended to reduce precisely those complications, with animal data suggesting the strategy works as intended.</p>
<p>Nevertheless, the trajectory is compelling. The convergence of additive manufacturing, patient-specific imaging and rigorous biomechanical simulation is reshaping how implants are conceived: no longer off-the-shelf rods, but engineered structures whose porosity, stiffness and geometry are tuned to the individual patient&#8217;s bone and loading demands. If subsequent large-animal studies with longer follow-up and, eventually, carefully controlled clinical trials confirm what this preclinical work suggests, the cloverleaf-sleeved, 3D-printed osseointegration prosthesis could move amputee rehabilitation closer to its long-promised goal — a prosthesis that feels less like an appliance strapped to the body and more like a genuine extension of the skeleton itself. For the millions who struggle daily with socket discomfort and instability, that future cannot come soon enough.</p>
<p><strong>Subject of Research:</strong> Preclinical development of a 3D-printed osseointegration prosthesis for residual limb reconstruction after amputation</p>
<p><strong>Article Title:</strong> A Preclinical Approach to 3D-Printed Osseointegration Prosthesis: Improving Functional Outcomes and Reducing Complications in Residual Limb Reconstruction</p>
<p><strong>Article References:</strong> A Preclinical Approach to 3D-Printed Osseointegration Prosthesis: Improving Functional Outcomes and Reducing Complications in Residual Limb Reconstruction. (n.d.). <a href="https://doi.org/10.1007/s10439-026-04401-5" rel="noopener noreferrer">https://doi.org/10.1007/s10439-026-04401-5</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1007/s10439-026-04401-5" rel="noopener noreferrer">10.1007/s10439-026-04401-5</a></p>
<p><strong>Keywords:</strong> osseointegration, 3D printing, prosthesis, finite element analysis, amputation, biomechanics, titanium implant, bone anchoring, residual limb, preclinical study, biocompatibility, cloverleaf sleeve</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">221638</post-id>	</item>
		<item>
		<title>Mildly Alkaline Implant Surfaces Enlist Neutrophils to Fight Infection and Rebuild Bone</title>
		<link>https://scienmag.com/mildly-alkaline-implant-surfaces-enlist-neutrophils-to-fight-infection-and-rebuild-bone/</link>
		
		<dc:creator><![CDATA[Kristina Jarvis]]></dc:creator>
		<pubDate>Fri, 25 Sep 2026 02:08:03 +0000</pubDate>
				<category><![CDATA[Technology and Engineering]]></category>
		<category><![CDATA[biofilm disruption strategies]]></category>
		<category><![CDATA[biofilm-resistant implant surfaces]]></category>
		<category><![CDATA[bone regeneration]]></category>
		<category><![CDATA[bone regeneration with antibacterial surfaces]]></category>
		<category><![CDATA[host immune response to implants]]></category>
		<category><![CDATA[immune-guided antimicrobial strategies]]></category>
		<category><![CDATA[implant surface engineering]]></category>
		<category><![CDATA[implant-associated infection]]></category>
		<category><![CDATA[infection-resistant orthopedic devices]]></category>
		<category><![CDATA[interfacial pH]]></category>
		<category><![CDATA[mildly alkaline titanium implants]]></category>
		<category><![CDATA[neutrophil extracellular traps]]></category>
		<category><![CDATA[neutrophil recruitment for infection control]]></category>
		<category><![CDATA[neutrophils]]></category>
		<category><![CDATA[orthopedic implant infection prevention]]></category>
		<category><![CDATA[osseointegration]]></category>
		<category><![CDATA[osseointegration enhancement]]></category>
		<category><![CDATA[pH-responsive biomaterials]]></category>
		<category><![CDATA[reactive oxygen species]]></category>
		<category><![CDATA[S1PR2]]></category>
		<category><![CDATA[sphingolipid metabolism]]></category>
		<category><![CDATA[SPHK1]]></category>
		<category><![CDATA[Staphylococcus aureus]]></category>
		<category><![CDATA[titanium implant]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=214123</guid>

					<description><![CDATA[Researchers engineered a mildly alkaline titanium implant surface that reshapes neutrophil sphingolipid metabolism to promote NET formation, enhancing antibacterial defense while supporting bone repair.]]></description>
										<content:encoded><![CDATA[<p>Orthopedic implants have transformed the treatment of fractures and bone defects, yet implant-associated infection remains one of the most stubborn obstacles to long-term clinical success. When bacteria such as Staphylococcus aureus adhere to an implant surface in the early hours after surgery, they can form resilient biofilms that sustain local inflammation, disrupt the surrounding microenvironment, impair osseointegration, and ultimately force revision surgery and prolonged antimicrobial therapy. Most current strategies to combat this problem focus on making the material itself lethal to bacteria, through coatings that release antibiotics or metal ions, present antimicrobial peptides, or respond to external stimuli. These approaches can lower the initial bacterial burden, but their efficacy is often undermined by unstable release kinetics, difficulty maintaining effective local concentrations, and limited activity against established biofilms. A new study published in Materials Today Bio proposes a fundamentally different philosophy: instead of asking the implant to kill bacteria directly, researchers engineered a titanium surface that recruits the body&#8217;s own first responders to do the job.</p>
<p>The research team, led by Gaoquan Zheng, Dianqing Li, and colleagues, set out to test whether a deliberate local pH signal built into the implant interface could guide neutrophil behavior and strengthen host antibacterial defense without adding any exogenous bactericidal agent. Neutrophils are among the first innate immune cells recruited to infected sites, and beyond phagocytosis and degranulation they can release neutrophil extracellular traps, or NETs, which are extracellular chromatin-based networks that capture pathogens and limit their spread. Prior work had hinted that extracellular pH regulates this process: bicarbonate-rich pancreatic fluid has been shown to promote PADI4-dependent aggregated NET formation, a high bicarbonate-to-CO2 ratio and moderately alkaline pH favor NET release, and extracellular acidosis suppresses ROS-dependent NETosis. What remained poorly understood was how such a physicochemical cue is converted into functional changes inside the neutrophil, and whether it could be harnessed at a biomaterial surface.</p>
<p>To create the alkaline interface, the researchers subjected titanium plates to a hydrothermal reaction in a mixed sodium hydroxide and hydrogen peroxide solution at 80 degrees Celsius for 24 hours, followed by hydrochloric acid-mediated ion exchange to remove excess sodium-containing alkaline species and a thermal treatment ramping to 450 degrees Celsius. The resulting material, designated Ti-A, developed a uniform nanoscale porous architecture visible by scanning electron microscopy, in contrast to the relatively smooth pristine titanium surface. X-ray diffraction confirmed a mixed anatase and rutile TiO2 crystalline structure, and X-ray photoelectron spectroscopy detected a distinct sodium signal reflecting the incorporation of sodium-related species during alkali treatment. Critically, pH measurements taken approximately two millimeters above the surface showed that Ti-A maintained a local pH of roughly 7.88 in ultrapure water and, importantly, remained within a mildly alkaline range of about 7.49 to 7.78 even under physiological buffering conditions in PBS and cell culture medium over 48 hours.</p>
<p>The team then verified that this modified surface was compatible with the cells that matter. Rat bone marrow mesenchymal stem cells cultured on Ti-A retained well-organized F-actin cytoskeletons and intact nuclear morphology, with metabolic activity remaining approximately 92 percent of that observed on pristine titanium despite a modest but significant reduction. Neutrophils exposed to Ti-A for six hours retained roughly 89 percent of their CCK-8 metabolic signal, indicating that the interface did not cause extensive loss of neutrophil viability during the NET-induction period. With biocompatibility established, the researchers turned to the central question of whether Ti-A could trigger bona fide NET formation rather than nonspecific DNA leakage. SYTOX Green staining revealed more extracellular DNA-positive structures on Ti-A than on pristine Ti, and DNase I treatment markedly reduced these networks, confirming their dependence on a DNA scaffold.</p>
<p>Further molecular evidence strengthened the case. Ti-A markedly increased signals of citrullinated histone H3, a chromatin modification closely associated with NET formation, which colocalized with extracellular chromatin regions. Enzyme-linked immunosorbent assays showed higher levels of MPO-DNA complexes in the Ti-A group, indicating co-release of extracellular chromatin with neutrophil granule proteins, a biochemical hallmark of genuine NETs. When neutrophils and S. aureus were co-incubated on the surfaces for six hours, Ti-A achieved an antibacterial rate of approximately 86.67 percent compared with 47.50 percent on pristine titanium. Even without neutrophils present, Ti-A reduced bacterial survival, demonstrating intrinsic surface antibacterial activity, but the addition of neutrophils revealed a substantial host-mediated enhancement on top of that direct effect.</p>
<p>To dissect the mechanism, the researchers applied two pharmacological tools. DNase I, which degrades the extracellular DNA backbone of NETs, caused colony formation on Ti-A to rise sharply and the antibacterial rate to fall to a level close to that of Ti-A alone, indicating that NET-associated extracellular DNA structures were a major contributor to the enhanced killing. Cytochalasin D, which inhibits actin-dependent phagocytosis, also reduced the antibacterial rate, but it remained higher than that of Ti-A alone, suggesting that phagocytosis contributed without fully accounting for the neutrophil-mediated advantage. Together, these experiments established that beyond directly restricting bacterial survival, the alkaline interface amplified neutrophil extracellular killing as the dominant antibacterial mechanism.</p>
<p>The deepest insight of the study came from untargeted metabolomic profiling of neutrophils stimulated on the two surfaces. Volcano plot analysis revealed 77 upregulated and 7 downregulated metabolites in the Ti-A group, with lipid metabolism dominating the differential profile. Sphingosine and N-palmitoyl-D-sphingosine were elevated and ranked among the most important metabolites distinguishing Ti-A-stimulated neutrophils from controls, while 6-phosphogluconic acid, a metabolite of the oxidative pentose phosphate pathway that supplies NADPH for reactive oxygen species generation, was also increased. KEGG enrichment analysis placed sphingolipid metabolism and sphingolipid signaling among the top enriched pathways. This metabolic signature pointed the investigators toward a specific signaling axis: sphingosine can be phosphorylated by sphingosine kinase 1, or SPHK1, to generate sphingosine-1-phosphate, which signals through receptors including S1PR2 and may engage calcium- and MAPK-related pathways linked to PAD4 activation, histone H3 citrullination, chromatin decondensation, and NET formation.</p>
<p>Subsequent molecular and pharmacological experiments supported this model. Neutrophils on Ti-A showed markedly stronger intracellular oxidative signals by DCFH-DA fluorescence and flow cytometry, and both SPHK1 and S1PR2 were significantly upregulated at the mRNA and protein levels. Notably, PMA, a standard positive NET-inducing stimulus, enhanced oxidative activity without inducing comparable SPHK1 or S1PR2 increases, indicating that this upregulation is not a generic consequence of NET induction but is more closely tied to the sphingolipid remodeling triggered by Ti-A. When the researchers blocked the pathway with PF-543, a selective SPHK1 inhibitor, or with DPI, which suppresses NADPH oxidase-derived ROS production, both the web-like extracellular DNA structures and the intracellular oxidative signal were significantly attenuated. Because neither inhibitor completely abolished NET formation, the authors conclude that the SPHK1-S1PR2/ROS axis makes a substantial contribution while operating alongside other signaling events initiated at the interface.</p>
<p>The strategy then faced its most demanding test in vivo. Titanium and Ti-A implants preloaded with S. aureus were inserted into femoral condyle defects in rats. At three days after surgery, fewer colonies were recovered from peri-implant bone tissues in the Ti-A group, accompanied by stronger Ly6G neutrophil staining, enhanced H3Cit signals indicating histone citrullination, and elevated SPHK1 and S1PR2 expression at the interface. At two months, bacterial burden remained significantly lower around Ti-A implants, and micro-CT reconstruction showed more newly formed bone with significantly higher bone volume fraction and bone mineral density. Histology revealed richer bone matrix and collagen deposition, stronger osteopontin staining, and milder inflammatory infiltration, while H&amp;E staining of major organs showed no pathological damage, indicating no evident systemic toxicity.</p>
<p>Importantly, the modified interface did not trade immune-antibacterial activity for impaired osteogenic function. In vitro, Ti-A supported stronger alkaline phosphatase staining and activity, more extensive Alizarin Red S mineral deposition, and increased Runx2 and Col1a1 expression during osteogenic induction. The authors caution that the biological consequences of NET formation depend strongly on timing, magnitude, and clearance: early NETs can immobilize bacteria and assist macrophage-mediated killing, whereas persistent or excessive NETs may sustain inflammation and damage tissue. Their experiments did not track NET formation and clearance continuously, and serial measurements at intermediate time points will be needed to define how the response subsides as the interface shifts from infection control toward tissue repair. Nevertheless, the work positions mild interfacial alkalinity as a host-responsive design cue for anti-infective bone implants, offering a route to coordinate early infection control and subsequent bone regeneration that could hold particular translational value for patients facing infected bone defects where both problems must be solved concurrently.</p>
<p><strong>Subject of Research:</strong> Mildly alkaline titanium implant interfaces regulating neutrophil sphingolipid immunometabolism and NET formation for antibacterial host defense and bone repair</p>
<p><strong>Article Title:</strong> Interfacial mild alkalinity shapes Neutrophil immunometabolism through sphingolipid remodeling to enhance antibacterial host defense</p>
<p><strong>Article References:</strong> Interfacial mild alkalinity shapes Neutrophil immunometabolism through sphingolipid remodeling to enhance antibacterial host defense. (n.d.). <a href="https://doi.org/10.1016/j.mtbio.2026.103691" rel="noopener noreferrer">https://doi.org/10.1016/j.mtbio.2026.103691</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1016/j.mtbio.2026.103691" rel="noopener noreferrer">10.1016/j.mtbio.2026.103691</a></p>
<p><strong>Keywords:</strong> neutrophils, neutrophil extracellular traps, implant-associated infection, titanium implant, interfacial pH, sphingolipid metabolism, SPHK1, S1PR2, reactive oxygen species, Staphylococcus aureus, osseointegration, bone regeneration</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">214123</post-id>	</item>
	</channel>
</rss>
